1. Home
  2. CRDL vs ABVE Comparison

CRDL vs ABVE Comparison

Compare CRDL & ABVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRDL
  • ABVE
  • Stock Information
  • Founded
  • CRDL 2017
  • ABVE 2019
  • Country
  • CRDL Canada
  • ABVE Canada
  • Employees
  • CRDL N/A
  • ABVE N/A
  • Industry
  • CRDL Biotechnology: Biological Products (No Diagnostic Substances)
  • ABVE Packaged Foods
  • Sector
  • CRDL Health Care
  • ABVE Consumer Staples
  • Exchange
  • CRDL Nasdaq
  • ABVE Nasdaq
  • Market Cap
  • CRDL 90.4M
  • ABVE 90.1M
  • IPO Year
  • CRDL N/A
  • ABVE N/A
  • Fundamental
  • Price
  • CRDL $1.07
  • ABVE $3.20
  • Analyst Decision
  • CRDL Strong Buy
  • ABVE
  • Analyst Count
  • CRDL 2
  • ABVE 0
  • Target Price
  • CRDL $9.00
  • ABVE N/A
  • AVG Volume (30 Days)
  • CRDL 781.9K
  • ABVE 3.1M
  • Earning Date
  • CRDL 11-13-2025
  • ABVE 01-01-0001
  • Dividend Yield
  • CRDL N/A
  • ABVE N/A
  • EPS Growth
  • CRDL N/A
  • ABVE N/A
  • EPS
  • CRDL N/A
  • ABVE N/A
  • Revenue
  • CRDL N/A
  • ABVE $213,446,206.00
  • Revenue This Year
  • CRDL N/A
  • ABVE N/A
  • Revenue Next Year
  • CRDL N/A
  • ABVE N/A
  • P/E Ratio
  • CRDL N/A
  • ABVE N/A
  • Revenue Growth
  • CRDL N/A
  • ABVE N/A
  • 52 Week Low
  • CRDL $0.77
  • ABVE $0.25
  • 52 Week High
  • CRDL $2.24
  • ABVE $4.40
  • Technical
  • Relative Strength Index (RSI)
  • CRDL 44.27
  • ABVE 74.24
  • Support Level
  • CRDL $1.04
  • ABVE $1.56
  • Resistance Level
  • CRDL $1.16
  • ABVE $3.53
  • Average True Range (ATR)
  • CRDL 0.06
  • ABVE 0.30
  • MACD
  • CRDL 0.00
  • ABVE 0.19
  • Stochastic Oscillator
  • CRDL 18.00
  • ABVE 81.36

About CRDL Cardiol Therapeutics Inc.

Cardiol Therapeutics Inc is a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart diseases. The company's main product candidate, CardiolRx, is a pharmaceutically manufactured oral cannabidiol formulation that is being clinically developed for use in heart diseases. Cardiol has received Investigational New Drug Application authorization from the United States Food and Drug Administration to conduct clinical studies to evaluate the efficacy and safety of CardiolRx in two diseases affecting the heart which are a Phase II multi-national trial, the ARCHER trial, in acute myocarditis; and a Phase II multi-center open-label pilot study in recurrent pericarditis.

About ABVE Above Food Ingredients Inc. Common Stock

Above Food Ingredients Inc is a differentiated, regenerative ingredient company. Its products are made with real nutritious, flavorful ingredients and delivered with transparency. Its vision is to create a healthier world one seed, one field, and one bite at a time. With a robust chain of custody of plant proteins, enabled by scaled operations and infrastructure in primary agriculture and processing, and proprietary seed development capabilities that leverage the power of artificial intelligence driven genomics. The company delivers nutritious foods to businesses and consumers with traceability and sustainability. Above Food's consumer products and brands are available in grocers across Canada and the United States.

Share on Social Networks: